Sorrento Therapeutics, Inc.

UEI
KWEWLHZ59FL3
CAGE
5SPZ9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Website
sorrentotherapeutics.com
Founded
2009
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Sorrento Therapeutics, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
BAA research area 004 - "development of in vitro for biodefense, antimicrobial resistant (AMR) infections and emerging… Contract · 75N93023C00024 National Institute of Allergy and Infectious Diseases $4,590,862
Human anti-WISP1 antibodies for treatment of idiopathic pulmonary fbrosis Grant · R43HL122078 National Institutes of Health $224,823
Targeting of MYC-max dimerization for the treatment of cancer Grant · R41CA189600 National Institutes of Health $224,550
Anti-pseudomonas immunotherapy and targeted drug delivery Grant · R41AI114252 National Institutes of Health $586,535
Human monoclonal antibodies for prevention of s. Aureus infections Grant · R42AI098182 National Institutes of Health $2,595,459

Quick answers

What is Sorrento Therapeutics, Inc.'s UEI?

Sorrento Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is KWEWLHZ59FL3.

What is Sorrento Therapeutics, Inc.'s CAGE code?

Sorrento Therapeutics, Inc.'s CAGE code is 5SPZ9.

What is Sorrento Therapeutics, Inc.'s primary NAICS code?

Sorrento Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Sorrento Therapeutics, Inc. registered in SAM.gov?

Sorrento Therapeutics, Inc.'s SAM.gov registration expired on July 17, 2026.

What is Sorrento Therapeutics, Inc.'s most recent federal award?

Sorrento Therapeutics, Inc.'s most recent federal contract award is BAA research area 004 - "development of in vitro for biodefense, antimicrobial resistant (AMR) infections and emerging… (75N93023C00024), from National Institute of Allergy and Infectious Diseases, on June 1, 2023.

On GovTribe

See Sorrento Therapeutics, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login